E. G. Malelin
Research Subjects
E. G. Malelin has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- A. V. Markova
Petrovsky National Research Centre of Surgery
1 shared publication - F. Ya. Tukhasheva
Petrovsky National Research Centre of Surgery
1 shared publication - K. D. Mekhonoshin
Ye. A. Vagner Perm State Medical University
1 shared publication - Olga G. Goryacheva
Department of Polyclinic Therapy, Perm State Meical University named after Academician E.A. Wagner, Ministry of Health of the Russian Federation. 26 Petropavlovskaya St., Perm, Russian Federation
1 shared publication - V. G. Zhelobov
Ye. A. Vagner Perm State Medical University
1 shared publication Тухашева Ф. Я.
Пермский государственный медицинский университет имени академика Е.А. Вагнера
1 shared publication
Latest Publications
- Open Access
- 11 September 2025
- Published by ECO-Vector LLC (Publications) in Perm Medical Journal
- Vol. 42 (4) , 55-63
Analysis of the causes of lethal outcome in patients infected with human immunodeficiency virus
Over 37 million HIV-infected people live in the world and many of them die due to the progression and decompensation of somatic diseases. The aim of the study is to determine the rating of fatal outcomes causes of HIV-infected patients according to the data of the authors from different countries of the world. Data from 287 full-text articles were analyzed, from which 32 sources most relevant to the purpose of the study were selected. The leading causes of death in HIV-infected patients were infectious complications and opportunistic infections characteristic of the AIDS stage, along with concomitant tuberculosis infection (55.1 %). Cardiovascular diseases ranked second (20.6 %), followed by cancer (14.6 %), liver diseases, including alcoholic and viral hepatitis and cirrhosis (8.5 %), and only 1.1% are accounted for by all other diseases. Mortality from infective endocarditis, myocardial infarction, sudden cardiac death, acute cerebrovascular event, pulmonary embolism and acute decompensation of chronic heart failure together account for 82.5 % of all cardiovascular causes of mortality. Monitoring of patients with HIV infection should be comprehensive, involving infectious disease specialists, therapeutic and cardiology services, with increased cancer vigilance. The challenges of HIV infection concerning early development of cardiovascular pathology and elevated mortality from cardiovascular diseases should not be ignored.
- 11 September 2025
- Published by ECO-Vector LLC (Publications) in Perm Medical Journal
- Vol. 42 (4) , 55-63
Open AccessAnalysis of the causes of lethal outcome in patients infected with human immunodeficiency virus
Over 37 million HIV-infected people live in the world and many of them die due to the progression and decompensation of somatic diseases. The aim of the study is to determine the rating of fatal outcomes causes of HIV-infected patients according to the data of the authors from different countries of the world. Data from 287 full-text articles were analyzed, from which 32 sources most relevant to the purpose of the study were selected. The leading causes of death in HIV-infected patients were infectious complications and opportunistic infections characteristic of the AIDS stage, along with concomitant tuberculosis infection (55.1 %). Cardiovascular diseases ranked second (20.6 %), followed by cancer (14.6 %), liver diseases, including alcoholic and viral hepatitis and cirrhosis (8.5 %), and only 1.1% are accounted for by all other diseases. Mortality from infective endocarditis, myocardial infarction, sudden cardiac death, acute cerebrovascular event, pulmonary embolism and acute decompensation of chronic heart failure together account for 82.5 % of all cardiovascular causes of mortality. Monitoring of patients with HIV infection should be comprehensive, involving infectious disease specialists, therapeutic and cardiology services, with increased cancer vigilance. The challenges of HIV infection concerning early development of cardiovascular pathology and elevated mortality from cardiovascular diseases should not be ignored.